Kanaph Therapeutics Inc. (0082N0)
Market Closed
15 Oct, 06:30 AM
KRX SM KRX SM Primary ₩
9,400. 00
-620
-6.1876%
₩
214.99B Market Cap
- P/E Ratio
- Div Yield
77,934 Volume
- Eps
₩ 10,020
Previous Close Want to track 0082N0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kanaph Therapeutics Inc. (0082N0) Statistics
Valuation metrics
Market Cap 214.99B
Enterprise value 214.07B
Trailing P/E (ttm) -2.95
Forward P/E -
PEG ratio -
Price/Sales (ttm) 38.66
Price/Book (mrq) 3.74
Enterprise Value/Revenue 38.5
Enterprise Value/EBITDA -73.32
Overview
Shares outstanding 13.09M
Float -
Shares short -
% Held by insiders 0.36%
% Held by institutions 0.01%
Average volume (10 days) 61.96K
Average volume (90 days) 67.55K
Price summary
52-Week low 9,170
52-Week high 70,000
Beta -
50-Day moving average 13,914.2
200-Day moving average 24,431.59
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -
Operating margin -5.7%
Operational effectiveness
Return on assets -2.3%
Return on equity -2.87%
Income Statement
Revenue (ttm) 5.56B
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -0.98%
Gross profit (ttm) 5.56B
EBITDA -
Net income to common (ttm) -35.56B
Diluted EPS (ttm) -5,564
Quarterly earnings growth (yoy) -0.84%
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) 226.98M
Total Debt/Equity (mrq) 0
Current ratio (mrq) 34.01%
Book value per share (mrq) 4,384.86
Cash Flow
Cash flow statement -7.17B
Levered free cash flow (LFCF) -35.56B
2026 © Marketlog. All Rights Reserved.
